Annals of Diagnostic Pathology10.1016/j.anndiagpath.2019.01.00120193936-41Undifferentiated endometrial carcinoma: A selected immunohistochemical panel including PAX-8 and E-cadherin for aiding distinction from other endometrial carcinomasXiaofei Zhang, Minghua Yu,
Cancer Genetics and Cytogenetics10.1016/s0165-4608(97)82570-81996912137Analysis of chromosome 1-rearrangements in endometrial carcinomas by comparative genomic hybridization and loss of heterozygosityI. Hauspie, C. Bourgain, M. Kirsch-Volders,
Cancer10.1002/cncr.2277020071114217-223Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomasMichael Thrall, Klint Kjeldahl, H. Evin Gulbahce, Stefan E. Pambuccian,
The Journal of Pathology10.1002/path.267320092205551-561Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomasMonica Huszar, Marco Pfeifer, Uwe Schirmer, Helena Kiefel, Gottfried E Konecny, Alon Ben-Arie, Lutz Edler, Maria Münch, Elisabeth Müller-Holzner, Susanne Jerabek-Klestil, Samira Abdel-Azim, Christian Marth, Alain G Zeimet, Peter Altevogt, Mina Fogel,,
Histopathology10.1111/j.1365-2559.1982.tb02747.x198265493-510The endometrial hyperplasias and their relationship to endometrial neoplasiaH. FOX, C. H. BUCKLEY,
Cancer Letters10.1016/s0304-3835(01)00815-12002178143-51Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasiasBożena Konopka, Zygmunt Paszko, Aneta Janiec-Jankowska, Marian Goluda,
Gynecologic Oncology10.1016/j.ygyno.2020.05.5902020159324-325Does genomic loss of heterozygosity (gLOH) in endometrial carcinomas (EC) predict platinum sensitivity (PS)?B. Bustamante, B. Rice, R. Sinha, W. Shan, V.S. John, D.I. Lin, N. Danziger, D.C. Pavlick, G.L. Goldberg, J.A. Elvin, M. Frimer,
Virchows Archiv10.1007/s00428-008-0650-520084533223-231The endometrial hyperplasias revisitedEfthimios Sivridis, Alexandra Giatromanolaki,,
Journal of Cancer Research and Clinical Oncology10.1007/bf0137254619971238429-434Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findingsMakoto Saegusa, Isao Okayasu,,
International Journal of Gynecology & Obstetrics10.1016/s0020-7292(12)61567-72012119S652-S652M376 EXPRESSION OF E-CADHERIN IN HUMAN PRIMARY ENDOMETRIAL CARCINOMAS: CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSIS OF 30 CASESM. Varras, T. Vasilakaki, E. Skafida, A. Anastasiadis, C. Akrivis, G. Nikolopoulos,,,,